Pelthos Therapeutics Inc.
PTHS· NYSE
Released May 14, 2026, before the open
10-Q filed May 14, 2026, 44 days after period end · 0001919246-26-000070
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $10.91M | $0.00 | — | — |
| Net Income | -$25.07M | -$1.97M | -$2.56M | -$966.56K |
| EPS Diluted |
Pelthos Therapeutics Inc. · CIK 1919246 · Engraved from SEC EDGAR
| -$7.57 |
| -$3.21 |
| -$0.55 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.